Akums Drugs & Pharmaceuticals Ltd. (AKUMS): Akums Drugs & Pharmaceuticals Share Price Hits Fresh 52-Week High
- August 12, 2026
- Posted by: Harsh Piplani
- Category: News
Akums Drugs & Pharmaceuticals Ltd. traded at Rs 761.10, up 0.01% today, after hitting a fresh 52-week high of Rs 775.45. Market capitalisation stood at Rs 11,509.44 crore.
Akums Drugs & Pharmaceuticals Ltd. Share Price was at Rs 761.10 on 12 August 2026 at 11:17 AM IST, up 0.01% from the previous close of Rs 761.00, after the stock touched a fresh 52-week high of Rs 775.45 during the session. With a market capitalisation of Rs 11,509.44 crore, the Healthcare stock has moved onto the radar of investors tracking 52 Week High Stocks and intraday Market Movers.
The verified data confirms the price event clearly: Akums Drugs & Pharmaceuticals Ltd. (AKUMS) reached a new one-year high even though the day’s percentage move remained marginal. That contrast matters. A stock can register a yearly high not only on a large single-day jump, but also when it edges above prior trading ranges and sustains attention around elevated levels. In today’s Stock Market Today environment, that makes Akums Drugs & Pharmaceuticals Share Price relevant for both price-action watchers and investors comparing valuation against sector benchmarks.
What the supplied data establishes is the event itself, the trading range, turnover, volume and the company’s current valuation and profitability ratios. It also shows how the stock stands against the wider Healthcare sector and selected peers. For readers following Akums Drugs & Pharmaceuticals Share Price Today, Akums Drugs & Pharmaceuticals Stock News and broader Share Market Today developments, the next step is to examine whether the move is being supported by trading activity and how the company’s metrics compare with sector norms. Univest tracks that full context in a single view.
Akums Drugs & Pharmaceuticals Ltd. Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 761.1 |
| Previous Close | Rs 761 |
| Today's Change | +Rs 0.1 (+0.01%) |
| Day Open | Rs 761 |
| Fresh 52-Week High | Rs 775.45 |
| Day Low | Rs 754 |
| Current Volume | 10,440 |
| Turnover | Rs 0.79 crore |
| Market Capitalisation | Rs 11,509.44 crore |
Akums Drugs & Pharmaceuticals Ltd. (AKUMS) traded at Rs 761.1. versus the previous close of Rs 761, a rise of 0.01%. The stock opened at Rs 761, reached Rs 775.45, touched Rs 754. Reported volume was 10,440.
Akums Drugs & Pharmaceuticals Ltd. Share Price Today shows a stock that reached a fresh 52-week high intraday while ending only marginally above the previous close. The session data points to a wide trading range, continued participation and a price level that remains close to the stock’s new one-year high.
Akums Drugs & Pharmaceuticals Share Price opened at Rs 761.00, the same as the previous close of Rs 761.00, and later rose to Rs 775.45, which now stands as the fresh 52-week high and yearly high for the stock. The day’s low was Rs 754.00, placing the intraday range at Rs 21.45 between low and high. By the time of the article timestamp, the stock was trading at Rs 761.10, reflecting a day change of Rs 0.10 or 0.01%.
That combination is notable. The stock managed to print a new 52-week peak even though the live price was only slightly higher on the day. In practical terms, this means buyers were willing to test higher levels, but the stock also saw trading back from the session high. Turnover stood at Rs 0.79 crore, while current volume was 10,440 shares. For investors searching Akums Drugs & Pharmaceuticals Share Price Live or Akums Drugs & Pharmaceuticals Share Price Update, the numbers suggest a stock in focus because of the new high itself rather than because of a large percentage spike.
Since the supplied data confirms the fresh 52-week high but does not establish a company-specific catalyst, the event is best understood through verified price action and valuation context. That makes the next layer of Akums Drugs & Pharmaceuticals Stock Analysis especially important: whether the business metrics and sector positioning add support to investor attention. Univest therefore shifts from the tape to the balance-sheet lens.
Akums Drugs & Pharmaceuticals Ltd. (AKUMS) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 11,509.44 crore |
| P/E Ratio | 31.07x |
| P/B Ratio | 0.45x |
| ROE | -2.89% |
| ROCE | -0.26% |
Akums Drugs & Pharmaceuticals Ltd. was valued at a P/E ratio of 31.07x, a P/B ratio of 0.45x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.
Profitability and capital efficiency were represented by ROE of -2.89% and ROCE of -0.26%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Benchmark Scope | same sector |
| Company P/E Ratio | 31.07x |
| Benchmark Median P/E | 21.13x |
| Benchmark Average P/E | 65.01x |
| Benchmark P/E Range | 0x to 3,374.81x |
| Company P/B Ratio | 0.45x |
| Benchmark Median P/B | 1.9x |
| Company ROE | -2.89% |
| Benchmark Median ROE | 10.92% |
| Company ROCE | -0.26% |
| Benchmark Median ROCE | 13.29% |
| Company Market Capitalisation | Rs 11,509.44 crore |
| Benchmark Median Market Cap | Rs 142.81 crore |
Akums Drugs & Pharmaceuticals Ltd. (AKUMS) is classified under sector: Healthcare.
Akums Drugs & Pharmaceuticals Ltd. (AKUMS) has a P/E ratio of 31.07x, which is above the benchmark median of 21.13x, a difference of +47.04%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Akums Drugs & Pharmaceuticals Ltd. (AKUMS) has a ROE of -2.89%, which is below the benchmark median of 10.92%, a difference of -126.47%. Akums Drugs & Pharmaceuticals Ltd. (AKUMS) has a ROCE of -0.26%, which is below the benchmark median of 13.29%, a difference of -101.96%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Dishman Carbogen Amcis Ltd. | DCAL | 2,949.87 | 31.07 | 0.45 | -2.89 | -0.26 |
| Beta Drugs Ltd. | BETA | 2,775.9 | 71.31 | 11.28 | 18.65 | 22.17 |
| Sai Parenteral's Ltd. | SAIPARENT | 2,594.65 | 179.52 | 3.32 | 13.9 | 12.97 |
| Dr Agarwals Eye Hospital Ltd. | DRAGARWQ | 2,561.88 | 33.61 | 6.93 | -2.6 | 16.92 |
| NGL Fine-Chem Ltd. | NGLFINE | 2,140.53 | 44.41 | 6.49 | 27.9 | 33.91 |
Akums Drugs & Pharmaceuticals Ltd. (AKUMS) has a P/E ratio of 31.07x compared with the displayed peer median of 44.41x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of -2.89% compares with a peer median of 13.9% across the companies shown in the table. ROCE stood at -0.26% versus the displayed peer median of 16.92%, providing a capital-efficiency comparison. Akums Drugs & Pharmaceuticals Ltd. (AKUMS) has a market capitalisation of Rs 11,509.44 crore. Among the 5 peers shown, 0 have a larger market capitalisation.
Why Investors Are Watching Akums Drugs & Pharmaceuticals Ltd.
The stock is attracting attention because a fresh 52-week high often brings a company into momentum and valuation screens. In Akums’ case, the price event is clear, while the fundamental and sector data create a more nuanced picture worth tracking.
- Fresh price event: Akums Drugs & Pharmaceuticals Share Price touched Rs 775.45, marking a new 52-week high and one-year high.
- Current trading level: The stock was at Rs 761.10, up 0.01%, after opening at Rs 761.00 and moving between Rs 754.00 and Rs 775.45.
- Trading activity: Current volume stood at 10,440 shares with turnover of Rs 0.79 crore.
- Large market value: Market capitalisation of Rs 11,509.44 crore is far above the supplied Healthcare sector medians and averages.
- Valuation mix: P/E of 31.07 is above the sector median of 21.13, while P/B of 0.45 is below the sector median of 1.90.
- Profitability watchpoint: ROE of -2.89 and ROCE of -0.26 trail sector median and average levels.
About Akums Drugs & Pharmaceuticals Ltd.
Akums Drugs & Pharmaceuticals Ltd. (AKUMS) is part of the Healthcare sector. Based on the supplied dataset, the company is being tracked in the market alongside other Healthcare and Pharmaceuticals & Drugs names, and it currently commands a market capitalisation of Rs 11,509.44 crore.
Within the comparison set supplied for this article, Akums is evaluated against companies such as Dishman Carbogen Amcis, Beta Drugs, Sai Parenteral’s and NGL Fine-Chem, all of which operate within Healthcare, with several specifically tagged under Pharmaceuticals & Drugs. That places Akums in an industry context where investors often compare earnings valuation, book valuation and capital efficiency through P/E, P/B, ROE and ROCE.
For readers following Akums Drugs & Pharmaceuticals Latest News, Akums Drugs & Pharmaceuticals Company News and Akums Drugs & Pharmaceuticals Earnings-related screens, the main point from the available data is that the company is now in focus because of its fresh 52-week high, large market value and contrasting profitability profile versus sector benchmarks. On Univest, that makes Akums a stock to track not only for price action but also for how its comparative ratios evolve against Healthcare peers.
Track Akums Drugs & Pharmaceuticals Ltd. Share Price on Univest
Use Akums Drugs & Pharmaceuticals Ltd. (AKUMS) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
Investors tracking Akums Drugs & Pharmaceuticals Ltd. Share Price can use Univest to follow live share price moves, 52-week levels, valuation ratios, peer comparison and broader market insights in one place. The platform helps readers monitor Akums Drugs & Pharmaceuticals Share Price Today, Akums Drugs & Pharmaceuticals Market Cap, sector benchmarks and ongoing stock analysis without relying on isolated data points.
Because a fresh 52-week peak can draw attention from traders and long-term market watchers alike, Univest brings together price action, fundamental analysis, sector comparison and company-level context. For investors who want a structured view of Akums Drugs & Pharmaceuticals Share Price Live, Healthcare sector positioning and daily Market News, the stock remains a relevant name to monitor after today’s one-year high.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
What is Akums Drugs & Pharmaceuticals Share Price today?
Ans. Akums Drugs & Pharmaceuticals Share Price was Rs 761.10 at 11:17 AM IST on 12 August 2026. The stock was up 0.01% from the previous close of Rs 761.00 after touching a fresh 52-week high intraday.
What is the fresh 52-week high for Akums Drugs & Pharmaceuticals Ltd.?
Ans. The fresh 52-week high for Akums Drugs & Pharmaceuticals Ltd. is Rs 775.45. The stock reached that level during the session before trading at Rs 761.10, keeping the one-year high event central to today’s stock news.
Why is Akums Drugs & Pharmaceuticals Share Price in focus today?
Ans. The stock is in focus because it hit a fresh 52-week high of Rs 775.45 on 12 August 2026. The supplied data confirms the price event, along with a market capitalisation of Rs 11,509.44 crore.
How did Akums Drugs & Pharmaceuticals Share Price move during the day?
Ans. The stock opened at Rs 761.00, fell to a day low of Rs 754.00 and rose to a day high of Rs 775.45. It was later trading at Rs 761.10, showing a narrow net daily gain.
What was the trading volume and turnover in Akums today?
Ans. Akums recorded current volume of 10,440 shares and turnover of Rs 0.79 crore in the supplied session data. These figures show active participation around the stock’s fresh 52-week high and intraday price range.
What is the market capitalisation of Akums Drugs & Pharmaceuticals Ltd.?
Ans. Akums Drugs & Pharmaceuticals Ltd. had a market capitalisation of Rs 11,509.44 crore in the supplied data. That is far above the Healthcare sector benchmark median of Rs 142.81 crore and average of Rs 461.64 crore.
Is Akums expensive or cheap compared with the Healthcare sector?
Ans. Akums trades at a P/E of 31.07 versus the Healthcare sector median of 21.13 and average of 65.01. Its P/B is 0.45, which is below the sector median of 1.90 and average of 2.59.
How do Akums profitability ratios compare with the sector?
Ans. Akums has ROE of -2.89 and ROCE of -0.26 in the supplied dataset. Both are below the Healthcare sector median levels of 10.92 and 13.29, and also below the sector averages of 15.38 and 17.71.
How does Akums compare with peers on valuation and size?
Ans. Akums stands out on size, with market capitalisation of Rs 11,509.44 crore versus peer market caps between Rs 2,140.53 crore and Rs 2,949.87 crore. Its P/E of 31.07 is lower than several supplied peers but profitability is weaker.
Where can investors track Akums Drugs & Pharmaceuticals Share Price updates?
Ans. Investors can track Akums Drugs & Pharmaceuticals Share Price on Univest for live price updates, 52-week levels, valuation ratios, sector comparison and stock analysis. That helps place today’s fresh one-year high in a broader market context.
